S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:JAGXJaguar Health News Headlines

$0.73
-0.07 (-8.84 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.71
Now: $0.73
$0.83
50-Day Range
$0.48
MA: $0.63
$0.80
52-Week Range
$0.35
Now: $0.73
$1.66
Volume5.26 million shs
Average Volume2.52 million shs
Market Capitalization$42.89 million
P/E RatioN/A
Dividend YieldN/A
Beta0.96

Headlines

Jaguar Health (NASDAQ JAGX) News Headlines

Source:
DateHeadline
Jaguar Health to Host Investor Call August 13th at 8:30 a.m. Eastern Regarding Q2 2020 Financials and Business UpdatesJaguar Health to Host Investor Call August 13th at 8:30 a.m. Eastern Regarding Q2 2020 Financials and Business Updates
finance.yahoo.com - August 11 at 4:39 PM
Jaguar Health Announces Activation of Investigational New Drug (IND) for Crofelemer (Mytesi) for Prophylaxis and SymptJaguar Health Announces Activation of Investigational New Drug (IND) for Crofelemer (Mytesi) for Prophylaxis and Sympt
bloomberg.com - August 8 at 1:48 AM
Jaguar Health (NASDAQ:JAGX) Shares Gap Up to $0.74Jaguar Health (NASDAQ:JAGX) Shares Gap Up to $0.74
americanbankingnews.com - August 6 at 9:18 PM
Jaguar Health Announces Activation of Investigational New Drug (IND) for Crofelemer (Mytesi) for Prophylaxis and Symptomatic Relief of Cancer Therapy‑Related DiarrheaJaguar Health Announces Activation of Investigational New Drug (IND) for Crofelemer (Mytesi) for Prophylaxis and Symptomatic Relief of Cancer Therapy‑Related Diarrhea
finance.yahoo.com - August 6 at 9:00 AM
Jaguar Health (NASDAQ:JAGX) Trading 8.1% Higher Jaguar Health (NASDAQ:JAGX) Trading 8.1% Higher
americanbankingnews.com - August 5 at 7:50 PM
Jaguar Health (NASDAQ:JAGX) Shares Gap Down to $0.74Jaguar Health (NASDAQ:JAGX) Shares Gap Down to $0.74
www.americanbankingnews.com - July 23 at 8:38 PM
Jaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated July 21, 2020 for Lechlemer Plant-based Drug Candidate for CholeraJaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated July 21, 2020 for Lechlemer Plant-based Drug Candidate for Cholera
finance.yahoo.com - July 22 at 1:34 PM
Jaguar Health Reports Voting Results from July 21, 2020 Special Meeting of StockholdersJaguar Health Reports Voting Results from July 21, 2020 Special Meeting of Stockholders
finance.yahoo.com - July 21 at 10:20 PM
Jaguar Health (NASDAQ:JAGX) Shares Up 10.4%Jaguar Health (NASDAQ:JAGX) Shares Up 10.4%
www.americanbankingnews.com - July 20 at 7:06 PM
FDA Invites Jaguar Health to Expedite Submission of Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Chemotherapy-induced Diarrhea in DogsFDA Invites Jaguar Health to Expedite Submission of Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Chemotherapy-induced Diarrhea in Dogs
finance.yahoo.com - July 20 at 11:14 AM
BRIEF-Jaguar Health Says Oasis Capital Reported 9.99% Passive Stake In CoBRIEF-Jaguar Health Says Oasis Capital Reported 9.99% Passive Stake In Co
www.reuters.com - July 7 at 9:56 PM
Jaguar Health completes IND filing for Mytesi for cancer therapy‑related diarrheaJaguar Health completes IND filing for Mytesi for cancer therapy‑related diarrhea
seekingalpha.com - July 6 at 12:47 PM
Jaguar Health Subsidiary Napo Pharmaceuticals Completes Filing of Investigational New Drug Application for Crofelemer (Mytesi) for Symptomatic Relief of Cancer Therapy‑Related DiarrheaJaguar Health Subsidiary Napo Pharmaceuticals Completes Filing of Investigational New Drug Application for Crofelemer (Mytesi) for Symptomatic Relief of Cancer Therapy‑Related Diarrhea
finance.yahoo.com - July 6 at 12:47 PM
Jaguar Health Submits Final Major Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in DogsJaguar Health Submits Final Major Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs
finance.yahoo.com - July 2 at 8:34 AM
Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter an Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter an Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020
finance.yahoo.com - June 29 at 12:38 PM
Jaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Jaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
www.finanznachrichten.de - June 23 at 6:12 PM
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - June 23 at 6:12 PM
Preclinical Study Demonstrating Symptomatic Relief of Diarrhea in Dogs Receiving Neratinib in Combination with Crofelemer (Mytesi) Presented at American Association for Cancer Research Virtual Annual MeetingPreclinical Study Demonstrating Symptomatic Relief of Diarrhea in Dogs Receiving Neratinib in Combination with Crofelemer (Mytesi) Presented at American Association for Cancer Research Virtual Annual Meeting
finance.yahoo.com - June 23 at 12:55 PM
On World Rainforest Day, Jaguar Health Reinforces Commitment to Amazon Rainforest and Sustainable Harvesting Programs for Plant-based PharmaceuticalsOn World Rainforest Day, Jaguar Health Reinforces Commitment to Amazon Rainforest and Sustainable Harvesting Programs for Plant-based Pharmaceuticals
finance.yahoo.com - June 22 at 10:01 AM
Jaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Jaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
www.finanznachrichten.de - June 19 at 6:29 PM
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - June 19 at 6:29 PM
Edited Transcript of JAGX earnings conference call or presentation 15-May-20 12:30pm GMTEdited Transcript of JAGX earnings conference call or presentation 15-May-20 12:30pm GMT
finance.yahoo.com - June 3 at 1:12 PM
Jaguar Health +29% on final submission of Canalevia filing for diarrhea in dogsJaguar Health +29% on final submission of Canalevia filing for diarrhea in dogs
seekingalpha.com - May 29 at 12:31 PM
BRIEF-Jaguar Health Says NIAID Approved Napos Request For Testing Crofelemer Against 5 Viruses, Including SARS-CoV-2BRIEF-Jaguar Health Says NIAID Approved Napo's Request For Testing Crofelemer Against 5 Viruses, Including SARS-CoV-2
www.reuters.com - May 28 at 8:05 PM
Jaguar Health Submits Final Major Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Chemotherapy-induced Diarrhea in DogsJaguar Health Submits Final Major Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Chemotherapy-induced Diarrhea in Dogs
finance.yahoo.com - May 28 at 10:03 AM
Jaguar Health, Inc.: Jaguar Health Sustainability Leader Interviewed on Foodie Pharmacology PodcastJaguar Health, Inc.: Jaguar Health Sustainability Leader Interviewed on Foodie Pharmacology Podcast
www.finanznachrichten.de - May 26 at 9:20 AM
Jaguar Health Sustainability Leader Interviewed on Foodie Pharmacology PodcastJaguar Health Sustainability Leader Interviewed on Foodie Pharmacology Podcast
finance.yahoo.com - May 26 at 9:20 AM
Jaguar Health IncJaguar Health Inc
www.bloomberg.com - May 22 at 8:18 PM
Jaguar Health, Inc.: Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross ProceedsJaguar Health, Inc.: Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds
www.finanznachrichten.de - May 22 at 9:39 AM
Jaguar Health announces warrant exercises for up to ~9.1 sharesJaguar Health announces warrant exercises for up to ~9.1 shares
seekingalpha.com - May 22 at 9:39 AM
Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross ProceedsJaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds
finance.yahoo.com - May 22 at 9:39 AM
Jaguar Health Pursuing Contracting Opportunities with Insurers to Improve Patient Access for Companys Non-opioid Plant-Based Mytesi Drug ProductJaguar Health Pursuing Contracting Opportunities with Insurers to Improve Patient Access for Company's Non-opioid Plant-Based Mytesi Drug Product
finance.yahoo.com - May 20 at 8:46 AM
Jaguar Healths (JAGX) CEO Lisa Conte on Q1 2020 Results - Earnings Call TranscriptJaguar Health's (JAGX) CEO Lisa Conte on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 6:23 PM
Jaguar Health Reports Voting Results from May 15, 2020 Annual Meeting of StockholdersJaguar Health Reports Voting Results from May 15, 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 15 at 6:23 PM
Jaguar Health, Inc. Reports 2020 First Quarter Financial ResultsJaguar Health, Inc. Reports 2020 First Quarter Financial Results
finance.yahoo.com - May 15 at 8:21 AM
Jaguar Health inks accounts receivable deal with Oasis CapitalJaguar Health inks accounts receivable deal with Oasis Capital
seekingalpha.com - May 13 at 1:48 PM
Jaguar Health, Inc.: Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter Accounts Receivable Purchase Agreement with Oasis Capital, LLCJaguar Health, Inc.: Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter Accounts Receivable Purchase Agreement with Oasis Capital, LLC
www.finanznachrichten.de - May 13 at 8:47 AM
Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter Accounts Receivable Purchase Agreement with Oasis Capital, LLCJaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter Accounts Receivable Purchase Agreement with Oasis Capital, LLC
finance.yahoo.com - May 13 at 8:47 AM
Jaguar Health +11% on FDA approval of Canalevia for diarrhea in dogsJaguar Health +11% on FDA approval of Canalevia for diarrhea in dogs
seekingalpha.com - May 12 at 5:45 PM
Jaguar Health Clears Important Hurdle on Path to Approval of Canalevia (Crofelemer) to Treat Exercise-Induced Diarrhea (EID) in DogsJaguar Health Clears Important Hurdle on Path to Approval of Canalevia (Crofelemer) to Treat Exercise-Induced Diarrhea (EID) in Dogs
finance.yahoo.com - May 12 at 5:45 PM
Jaguar Health to Host Investor Call May 15th at 8:30 a.m. Eastern Regarding Q1 2020 Financials & Business UpdatesJaguar Health to Host Investor Call May 15th at 8:30 a.m. Eastern Regarding Q1 2020 Financials & Business Updates
finance.yahoo.com - May 12 at 5:45 PM
Jaguar Health says recent drug price hikes not tied to COVID-19 pandemicJaguar Health says recent drug price hikes not tied to COVID-19 pandemic
www.nasdaq.com - May 5 at 10:57 PM
Called out for tripling price of potential drug for Covid patients, company says increase planned for monthsCalled out for tripling price of potential drug for Covid patients, company says increase planned for months
www.bizjournals.com - May 5 at 5:56 PM
Pricing of Covid-19 Products Will Face Public ScrutinyPricing of Covid-19 Products Will Face Public Scrutiny
finance.yahoo.com - May 3 at 4:54 PM
Jaguar Health, Inc.: Jaguar Health Enters Deal with Atlas Sciences to Develop NP-500, a Jaguar Non-Core Plant-based Type II Diabetes Drug CandidateJaguar Health, Inc.: Jaguar Health Enters Deal with Atlas Sciences to Develop NP-500, a Jaguar Non-Core Plant-based Type II Diabetes Drug Candidate
www.finanznachrichten.de - April 16 at 12:19 PM
Jaguar Health Enters Deal with Atlas Sciences to Develop NP-500, a Jaguar Non-Core Plant-based Type II Diabetes Drug CandidateJaguar Health Enters Deal with Atlas Sciences to Develop NP-500, a Jaguar Non-Core Plant-based Type II Diabetes Drug Candidate
finance.yahoo.com - April 16 at 12:19 PM
Edited Transcript of JAGX earnings conference call or presentation 6-Apr-20 12:30pm GMTEdited Transcript of JAGX earnings conference call or presentation 6-Apr-20 12:30pm GMT
finance.yahoo.com - April 7 at 4:20 PM
Jaguar Health Reports 2019 Financial Results and Business UpdatesJaguar Health Reports 2019 Financial Results and Business Updates
finance.yahoo.com - April 6 at 4:36 PM
Jaguar Health to host investor call on April 6Jaguar Health to host investor call on April 6
seekingalpha.com - April 3 at 3:38 PM
Jaguar Health to Host Investor Call April 6th at 8:30 a.m. Eastern Regarding Q4 2019 Financials & Business UpdatesJaguar Health to Host Investor Call April 6th at 8:30 a.m. Eastern Regarding Q4 2019 Financials & Business Updates
finance.yahoo.com - April 3 at 3:38 PM
This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.